Tumor-associated myeloid cells can be activated in vitro and in vivo to mediate antitumor effects
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tumor-associated myeloid cells can be activated in vitro and in vivo to mediate antitumor effects
Authors
Keywords
-
Journal
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume 61, Issue 10, Pages 1683-1697
Publisher
Springer Nature
Online
2012-03-06
DOI
10.1007/s00262-012-1236-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Subsets of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice
- (2014) J.-I. Youn et al. JOURNAL OF IMMUNOLOGY
- Nitric oxide short-circuits interleukin-12-mediated tumor regression
- (2011) Nejat K. Egilmez et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- CpG Blocks Immunosuppression by Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice
- (2011) C. Zoglmeier et al. CLINICAL CANCER RESEARCH
- Impaired lymphatic contraction associated with immunosuppression
- (2011) S. Liao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans
- (2011) G. L. Beatty et al. SCIENCE
- Targeted Inhibition of Inducible Nitric Oxide Synthase Inhibits Growth of Human Melanoma In vivo and Synergizes with Chemotherapy
- (2010) A. G. Sikora et al. CLINICAL CANCER RESEARCH
- Myeloid-derived suppressor cell heterogeneity and subset definition
- (2010) Elisa Peranzoni et al. CURRENT OPINION IN IMMUNOLOGY
- T regulatory cells in cancer: recent advances and therapeutic potential
- (2010) Eyad Elkord et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Anti-tumour synergy of cytotoxic chemotherapy and anti-CD40 plus CpG-ODN immunotherapy through repolarization of tumour-associated macrophages
- (2010) Ilia N. Buhtoiarov et al. IMMUNOLOGY
- Macrophage-dependent nitric oxide expression regulates tumor cell detachment and metastasis after IL-2/anti-CD40 immunotherapy
- (2010) Jonathan M. Weiss et al. JOURNAL OF EXPERIMENTAL MEDICINE
- CTL Induction of Tumoricidal Nitric Oxide Production by Intratumoral Macrophages Is Critical for Tumor Elimination
- (2010) R. D. V. Miguel et al. JOURNAL OF IMMUNOLOGY
- Alternatively Activated Macrophage Possess Antitumor Cytotoxicity That Is Induced by IL-4 and Mediated by Arginase-1
- (2010) Julia I. Ellyard et al. JOURNAL OF IMMUNOTHERAPY
- Enhanced T-cell-independent Antitumor Effect of Cyclophosphamide Combined With Anti-CD40 mAb and CpG in Mice
- (2010) Erik E. Johnson et al. JOURNAL OF IMMUNOTHERAPY
- Tumor-infiltrating, myeloid-derived suppressor cells inhibit T cell activity by nitric oxide production in an intracranial rat glioma+vaccination model
- (2010) Wentao Jia et al. JOURNAL OF NEUROIMMUNOLOGY
- Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF
- (2009) Luigi Dolcetti et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Myeloid-derived suppressor cell activation by combined LPS and IFN-γ treatment impairs DC development
- (2009) Verena Greifenberg et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Tumor immunosuppressive environment: effects on tumor-specific and nontumor antigen immune responses
- (2009) Ana Paula de Souza et al. Expert Review of Anticancer Therapy
- Tumoricidal Effects of Activated Macrophages in a Mouse Model of Chronic Lymphocytic Leukemia
- (2009) Q.-L. Wu et al. JOURNAL OF IMMUNOLOGY
- IL4Rα + Myeloid-Derived Suppressor Cell Expansion in Cancer Patients
- (2009) Susanna Mandruzzato et al. JOURNAL OF IMMUNOLOGY
- Gr1+ Inflammatory Monocytes Are Required for Mucosal Resistance to the Pathogen Toxoplasma gondii
- (2008) Ildiko R. Dunay et al. IMMUNITY
- Tumoricidal activity of endothelium-derived NO and the survival of metastatic cells with high GSH and Bcl-2 levels
- (2008) Angel Ortega et al. NITRIC OXIDE-BIOLOGY AND CHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More